Hindilerden, F.; Yonal-Hindilerden, I.; Yenerel, M.N.; Nalcaci, M.; Diz-Kucukkaya, R.
Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen. Hematol. Rep. 2022, 14, 222-227.
https://doi.org/10.3390/hematolrep14030030
AMA Style
Hindilerden F, Yonal-Hindilerden I, Yenerel MN, Nalcaci M, Diz-Kucukkaya R.
Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen. Hematology Reports. 2022; 14(3):222-227.
https://doi.org/10.3390/hematolrep14030030
Chicago/Turabian Style
Hindilerden, Fehmi, Ipek Yonal-Hindilerden, Mustafa Nuri Yenerel, Meliha Nalcaci, and Reyhan Diz-Kucukkaya.
2022. "Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen" Hematology Reports 14, no. 3: 222-227.
https://doi.org/10.3390/hematolrep14030030
APA Style
Hindilerden, F., Yonal-Hindilerden, I., Yenerel, M. N., Nalcaci, M., & Diz-Kucukkaya, R.
(2022). Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen. Hematology Reports, 14(3), 222-227.
https://doi.org/10.3390/hematolrep14030030
